Plasma levels of middle molecules to estimate residual kidney function in haemodialysis without urine collection

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Vilar, Enric ^a,b   Boltiador, Capella ^a,c   Wong, Jonathan ^a,b   Viljoen, Adie ^a   Machado, Ashwini ^a   Uthayakumar, Arani ^a   Farrington, Ken ^a,b  

^a LISTER HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; CYSTATIN C; UREA;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT IDENTIFICATION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RENAL CLEARANCE; RESIDUAL KIDNEY FUNCTION; URINALYSIS; BLOOD; KIDNEY; KIDNEY DISEASES; PATHOPHYSIOLOGY; SURVIVAL ANALYSIS;

BETA 2-MICROGLOBULIN; CYSTATIN C; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; RENAL DIALYSIS; SURVIVAL ANALYSIS;

EID: 84955464727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143813     Document Type: Article

References (41)

1. Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant. 2009; 24 (8):2502-10. Epub 2009/02/26. doi: gfp071 [pii] doi: 10.1093/ndt/gfp071 PMID: 19240122.
2. Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis. 2001; 38(1):85-90. Epub 2001/06/30. doi: S0272-6386(01)14302-7 [pii] doi: 10.1053/ajkd.2001.25198 PMID: 11431186.
3. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang SM, Zhu X, Lazarus JM. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis. 1999; 33(3):523-34. Epub 1999/03/10. doi: S0272-6386(99)70190-3 [pii]. PMID: 10070917.
4. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001; 12 (10):2158-62. Epub 2001/09/20. PMID: 11562415.
5. Kjaergaard KD, Rehling M, Jensen JD, Jespersen B. Reliability of endogenous markers for estimation of residual renal function in haemodialysis patients. Clin Physiol Funct Imaging. 2013; 33(3):224-32. Epub 2013/03/26. doi: 10.1111/cpf.12018 PMID: 23522017.
6. Hoek FJ, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level. Nephrol Dial Transplant. 2007; 22 (6):1633-8. Epub 2007/04/04. doi: gfm027 [pii] doi: 10.1093/ndt/gfm027 PMID: 17403704.
7. Carter JL, Lane CE, Fan SL, Lamb EJ. Estimation of residual glomerular filtration rate in peritoneal dialysis patients using cystatin C: comparison with 51Cr-EDTA clearance. Nephrol Dial Transplant. 2011; 26(11):3729-32. doi: gfr112 [pii] doi: 10.1093/ndt/gfr112 PMID: 21441400.
8. Mulay A, Biyani M, Akbari A. Cystatin C and residual renal function in patients on peritoneal dialysis. Am J Kidney Dis. 2008; 52(1):194-5; author reply 5-6. Epub 2008/07/01. doi: S0272-6386(08)00873-1 [pii] doi: 10.1053/j.ajkd.2008.04.022 PMID: 18589221.
9. Gerhardt T, Poge U, Stoffel-Wagner B, Klein B, Klehr HU, Sauerbruch T, et al. Serum levels of beta-trace protein and its association to diuresis in haemodialysis patients. Nephrol Dial Transplant. 2008; 23(1):309-14. Epub 2007/08/25. doi: gfm510 [pii] doi: 10.1093/ndt/gfm510 PMID: 17717031.
10. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol. 1992; 38 Suppl 1:S20-7. Epub 1992/01/01. PMID: 1284235.
11. Grubb AO. Cystatin C-properties and use as diagnostic marker. Adv Clin Chem. 2000; 35:63-99. Epub 2000/10/21. PMID: 11040958.
12. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000; 36(1):29-34. Epub 2000/06/30. doi: S0272-6386(00)75804-5 [pii] doi: 10.1053/ajkd.2000.8237 PMID: 10873868.
13. Vinge E, Lindergard B, Nilsson-Ehle P, Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest. 1999; 59 (8):587-92. Epub 2000/02/26. PMID: 10691049.
14. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C - a new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 1998; 101(5):875-81.Epub 1998/05/23. PMID: 9565418.
15. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008; 51(3):395-406. Epub 2008/02/26. doi: S0272-6386(07)01594-6 [pii] doi: 10.1053/j.ajkd.2007.11.018 PMID: 18295055; PubMed Central PMCID: PMC2390827.
16. Fry AC, Singh DK, Chandna SM, Farrington K. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif. 2007; 25(3):295-302. Epub 2007/07/12. doi: 000104870 [pii] doi: 10.1159/000104870 PMID: 17622712.
17. Lopez-Menchero R, Miguel A, Garcia-Ramon R, Perez-Contreras J, Girbes V. Importance of residual renal function in continuous ambulatory peritoneal dialysis: its influence on different parameters of renal replacement treatment. Nephron. 1999; 83(3):219-25. Epub 1999/10/26. doi: 45514 [pii]. PMID: 10529628.
18. Amici G, Virga G, Da Rin G, Grandesso S, Vianello A, Gatti P, et al. Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis. Nephron. 1993; 65(3):469-71. Epub 1993/01/01. PMID: 8290003.
19. Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K. Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol. 2009; 4 (12):1944-53. Epub 2009/10/13. doi: CJN.05560809 [pii] doi: 10.2215/CJN.05560809 PMID: 19820129; PubMed Central PMCID: PMC2798875.
20. Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int. 2006; 69(11):2087-93. Epub 2006/04/28. doi: 5000447 [pii] doi: 10.1038/sj.ki.5000447 PMID: 16641921.
21. Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Carreras J, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013; 24(3):487-97. Epub 2013/02/16. doi: ASN.2012080875 [pii] doi: 10.1681/ASN.2012080875 PMID: 23411788; PubMed Central PMCID: PMC3582206.
22. Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant. 2013; 28(1):192-202. Epub 2012/12/12. doi: gfs407 [pii] doi: 10.1093/ndt/gfs407 PMID: 23229932.
23. Xu XQ, Gruner N, Al-Bashir A, Trutt-Ibing CH, Melzer H, Fassbinder W, et al. Determination of extra renal clearance and generation rate of beta2-microglobulin in hemodialysis patients using a kinetic model. ASAIO J. 2001; 47(6):623-7. PMID: 11730200.
24. Vilar E, Boltiador C, Viljoen A, Machado A, Farrington K. Removal and rebound kinetics of cystatin C in high-flux hemodialysis and hemodiafiltration. Clin J Am Soc Nephrol. 2014; 9(7):1240-7. Epub 2014/05/03. doi: CJN.07510713 [pii] doi: 10.2215/CJN.07510713 PMID: 24789553; PubMed Central PMCID: PMC4078955.
25. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis. 2006; 48 Suppl 1:S2-90. Epub 2006/07/04. doi: S0272-6386(06)00554-3 [pii] doi: 10.1053/j.ajkd.2006.03.051 PMID: 16813990.
26. Depner TA. Hemodialysis adequacy: basic essentials and practical points for the nephrologist in training. Hemodial Int. 2005; 9(3):241-54. Epub 2005/09/30. doi: HDI1138 [pii] doi: 10.1111/j.1492-7535.2005.01138.x PMID: 16191074.
27. Gotch FA. Kinetic Modelling in Hemodialysis. In: Nissenson AR, Fine RN, Gentile DE, editors. Clinical dialysis. 3rd ed. ed. Norwalk, CT: Appleton & Lange; 1995. p. 156-88.
28. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993; 4(5):1205-13. Epub 1993/11/01. PMID: 8305648.
29. Tattersall JE, DeTakats D, Chamney P, Greenwood RN, Farrington K. The post-hemodialysis rebound: predicting and quantifying its effect on Kt/V. Kidney Int. 1996; 50(6):2094-102. Epub 1996/12/01. PMID: 8943495.
30. Sjostrom P, Tidman M, Jones I. Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest. 2005; 65(2):111-24. Epub 2005/07/20. PMID: 16025834.
31. Leypoldt JK, Schmidt B, Gurland HJ. Measurement of backfiltration rates during hemodialysis with highly permeable membranes. Blood Purif. 1991; 9(2):74-84. Epub 1991/01/01. PMID: 1760145.
32. Merz GS, Benedikz E, Schwenk V, Johansen TE, Vogel LK, Rushbrook JI, et al. Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J Cell Physiol. 1997; 173(3):423-32. Epub 1997/11/25. doi: 10.1002/(SICI)1097-4652(199712)173:3〈423::AID-JCP15〉3.0.CO;2-C [pii]. PMID: 9369956.
33. Ghiso J, Saball E, Leoni J, Rostagno A, Frangione B. Binding of cystatin C to C4: the importance of sense-antisense peptides in their interaction. Proc Natl Acad Sci U S A. 1990; 87(4):1288-91. Epub 1990/02/01. PMID: 2304899; PubMed Central PMCID: PMC53459.
34. Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem. 1997; 43(6 Pt 1):1016-22. Epub 1997/06/01. PMID: 9191555.
35. Hofmann B, Wang YX, Cumberland WG, Detels R, Bozorgmehri M, Fahey JL. Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. AIDS. 1990; 4(3):207-14. PMID: 1972020.
36. Greipp PR, Katzmann JA, O'Fallon WM, Kyle RA. Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma. Blood. 1988; 72 (1):219-23. PMID: 3291982.
37. Odell RA, Slowiaczek P, Moran JE, Schindhelm K. Beta 2-microglobulin kinetics in end-stage renal failure. Kidney Int. 1991; 39(5):909-19. PMID: 2067207.
38. Marsenic O, Wierenga A, Wilson DR, Anderson M, Shrivastava T, Simon GA, et al. Comparison of cystatin C and Beta-2-microglobulin kinetics in children on maintenance hemodialysis. Hemodial Int. 2013; 17 Suppl 1:S11-6. Epub 2013/10/30. doi: 10.1111/hdi.12083 PMID: 24134324.
39. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol. 2000; 11(12):2344-50. Epub 2000/11/30. PMID: 11095657.
40. Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D'Haenens P. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations. Nephrol Dial Transplant. 2000; 15 Suppl 1:49-54. Epub 2000/03/29. PMID: 10737167.
41. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation. 2007; 115(2):173-9. Epub 2006/12/28. doi: CIRCULATIONAHA.106.644286 [pii] doi: 10.1161/CIRCULATIONAHA.106.644286 PMID: 17190862; PubMed Central PMCID: PMC2771187.